- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03393559
Effect of Leg Elevation on Prevention of Intraoperative Hypotension During Beach Chair Position
December 26, 2019 updated by: Jin-Tae Kim, Seoul National University Hospital
The Effect of Leg Elevation on the Prevention of Intraoperative Hypotension During Shoulder Surgery in the Beach Chair Position
The aim of this study is to evaluate the effect of leg elevation on the prevention of intraoperative hypotension during shoulder surgery in the Beach-chair position.
patients undergoing shoulder surgery in the Beach-chair position will be randomly assigned to Group L (with leg elevation) or Group C (no intervention).
The primary outcome is the incidence of intraoperative hypotension (mean blood pressure < 60mmHg or systolic blood pressure < 80% of baseline).
Secondary outcomes are the incidence of intraoperative cerebral desaturation (cerebral oxygen saturation < 80% of baseline, longer than 30 seconds), total amounts of administered inotropic agents, and systolic blood pressure, heart rate, and cerebral oxygen saturation at various time points.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult patients undergoing shoulder surgery in the beach chair position
Exclusion Criteria:
- Patients with myocardial infarction
- Patients with pacemaker
- Patients with cerebrovascular disease
- patients with arteriovenous fistula at the opposite arm
- Patients with autonomic nerve disorders
- Patients with hip or knee joint disorder limiting hip or knee flexion
- BMI > 30 kg/m2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group L
leg elevation during the beach chair position
|
Patients' leg will be raised by a pillow under both legs and the hip and knee joints will be flexed 45 degrees to position both knees at the heart level.
|
|
No Intervention: Group C
Patients' leg will be straightened without any intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of intraoperative hypotension
Time Frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
|
Mean blood pressure < 60 mmHg or systolic blood pressure < 80% of baseline
|
From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of intraoperative cerebral desaturation
Time Frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
|
Cerebral oxygen saturation < 80% of baseline longer than 30 seconds
|
From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
|
|
Total amounts of administered inotropic agents
Time Frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
|
Total amounts of administered inotropic agents after the Beach-chair positioning
|
From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
|
|
Systolic blood pressure
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
Systolic blood pressure in mmHg at multiple time-points
|
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
|
Heart rate
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
Heart rate in bpm at multiple time-points
|
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
|
Peripheral oxygen saturation
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
Peripheral oxygen saturation in percentage at multiple time-points
|
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
|
Cerebral oxygen saturation
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
Cerebral oxygen saturation in percentage at multiple time-points
|
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 24, 2018
Primary Completion (Actual)
December 11, 2019
Study Completion (Actual)
December 21, 2019
Study Registration Dates
First Submitted
December 26, 2017
First Submitted That Met QC Criteria
January 5, 2018
First Posted (Actual)
January 8, 2018
Study Record Updates
Last Update Posted (Actual)
December 27, 2019
Last Update Submitted That Met QC Criteria
December 26, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-1712-023-903
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Sharing Time Frame
IPD will be made available after article publication, for 3 years from the study completion.
IPD Sharing Access Criteria
Proposals should be directed to the corresponding author and will be reviewed by the study group.
Only requests that have a methodologically sound proposal and whose proposed use of the data has been approved by the independent review committee will be considered.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Ischemia
-
Assiut UniversityCompletedSubarachnoid Hemorrhage | Delayed Cerebral Ischemia | Cerebral VasospasmEgypt
-
Icahn School of Medicine at Mount SinaiCompletedSubarachnoid Hemorrhage | Delayed Cerebral Ischemia | Cerebral VasospasmUnited States
-
Nova Scotia Health AuthorityActive, not recruitingSubarachnoid Hemorrhage | Delayed Cerebral Ischemia | Cerebral Vasospasm | CT PerfusionCanada
-
Hospital Universitario Dr. Jose E. GonzalezCompleted
-
Egyptian Cerebro-Cardio-Vascular AssociationUnknownRisk Factor, Cardiovascular | Ischemia, Myocardial | Ischemia, Cerebral
-
Medical University of ViennaUniversity of Vienna; Austrian Science Fund (FWF)RecruitingSubarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Vasospasm, CerebralAustria
-
NoNO Inc.University of British Columbia; University of Toronto; University of Calgary; Genome... and other collaboratorsCompletedAcute Cerebral IschemiaCanada
-
El Instituto Nacional de Neurologia y Neurocirugia...CompletedBrain Ischemia | Subarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralMexico
-
Oregon Health and Science UniversityGlaxoSmithKline; Foundation for Anesthesia Education and ResearchCompletedEndothelial Dysfunction | Subarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Vasospasm, CerebralUnited States
-
Gachon University Gil Medical CenterWithdrawnCerebral Ischemia-HypoxiaKorea, Republic of
Clinical Trials on leg elevation
-
Samsung Medical CenterCompletedInfants or Children Undergoing Open Heart SurgeryKorea, Republic of
-
Nitte UniversityUnknownPropofol Induced HypotensionIndia
-
Navamindradhiraj UniversityActive, not recruitingEsmarch Bandages | Simple Leg ElevationThailand
-
Mongi Slim HospitalUnknownEffects of; Anesthesia, Spinal and Epidural, in PregnancyTunisia
-
Seoul National University HospitalCompletedIschemic Heart Disease | Cardiac Valve DiseaseKorea, Republic of
-
Seçil YavaşCompletedMaternal Hypotension Associated With Spinal Anesthesia During Cesarean SectionTurkey (Türkiye)
-
Cairo UniversityCompletedHypoperfusion | Spinal HypotensionEgypt
-
TriHealth Inc.Completed
-
Cairo UniversityUnknownPost-induction HypotensionEgypt
-
Misr International UniversitySuez Canal UniversityCompletedMarginal Bone Levels | Open Sinus Elevation | Closed Sinus ElevationEgypt